Get startedLog in
    Picture of Valbiotis SA logo

    ALVAL — Valbiotis SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Valbiotis launches "pivotal" REVERSE-IT clinical trial of VALEDIA

    Picture of Valbiotis SA logoValbiotis SA
    08/11/2017 16:36
    Nov 8 (Reuters) - VALBIOTIS SAS  ALVAL.PA : 
    * VALBIOTIS: VALEDIA: LAUNCH OF "PIVOTAL" REVERSE-IT 
CLINICAL 
TRIAL TO OBTAIN A HEALTH CLAIM 
    * FIRST SUBJECTS WILL BE INCLUDED IN TRIAL EARLY 2018 
    * INCREASED FINANCIAL SUPPORT FROM PUBLIC PARTNER 
INSTITUTIONS, 
UP TO MEUR 1,05 SINCE SEPTEMBER 2017 
 
Source text for Eikon:  ID:nBw22fFSa  
Further company coverage:  ALVAL.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))

    Recent news on Valbiotis SA

    See all news